Related Articles |
Safety of long-acting ?2-agonists in asthma.
Lancet Respir Med. 2016 Sep 21;
Authors: Rishton L
PMID: 27665514 [PubMed – as supplied by publisher]
View full post on pubmed: asthma
Related Articles |
Safety of long-acting ?2-agonists in asthma.
Lancet Respir Med. 2016 Sep 21;
Authors: Rishton L
PMID: 27665514 [PubMed – as supplied by publisher]
View full post on pubmed: asthma
Related Articles |
Determinants of longitudinal health-related quality of life change in children with asthma from low-income families: a report from the PROMIS(®) Pediatric Asthma Study.
Clin Exp Allergy. 2016 Sep 24;
Authors: Li Z, Leite W, Thompson L, Gross HE, Shenkman E, Reeve BB, DeWalt DA, Huang IC
Abstract
BACKGROUND: How the longitudinal asthma control status and other socio-demographic factors influence the changes of health-related quality of life (HRQOL) among asthmatic children, especially from low-income families, has not been fully investigated.
OBJECTIVES: This study aimed to describe the trajectories of asthma-specific HRQOL over 15 months, and examine the effect of asthma control status on HRQOL by taking socio-demographic factors into consideration.
METHODS: 229 dyads of asthmatic children and their parents enrolled in public insurance programs were recruited for assessing asthma control status and HRQOL over 4 time points of assessment. Asthma control status was measured using the Asthma Control and Communication Instrument and asthma-specific HRQOL was assessed using the Patient-Reported Outcomes Measurement Information System’s Pediatric Asthma Impact Scale. Latent growth models (LGMs) were applied to examine the trajectory of HRQOL and the factors contributing to the changes of HRQOL.
RESULTS: Unconditional LGM revealed that HRQOL was improved over time. Conditional LGM suggested that accounting for asthma control and participants’ socio-demographic factors, the variation in the initial level of HRQOL was significant, yet the rate of change was not. Conditional LGM also revealed that poorly-controlled asthma status was associated with poor HRQOL at each time point (p’s<0.05). Lower parental education was associated with lower baseline HRQOL (p<0.05). Hispanic children had a larger increase in HRQOL over time (p<0.01) than non-Hispanic White children.
CONCLUSIONS: Vulnerable socio-demographic characteristics and poorly controlled asthma status affect HRQOL in children. This finding encourages interventions to improve asthma control status and HRQOL in minority children. This article is protected by copyright. All rights reserved.
PMID: 27664979 [PubMed – as supplied by publisher]
View full post on pubmed: asthma
Condition: Asthma
Intervention: Behavioral: Electronic sensor and OW education
Sponsor: Montefiore Medical Center
Not yet recruiting – verified September 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Related Articles |
Step 4: stick or twist? A review of asthma therapy.
BMJ Open Respir Res. 2016;3(1):e000143
Authors: Slater MG, Pavord ID, Shaw DE
Abstract
Many people with asthma do not achieve disease control, despite bronchodilators and inhaled corticosteroid therapy. People with uncontrolled asthma are at higher risk of an asthma attack and death, with mortality rates estimated at 1000 deaths/year in England and Wales. The recent National Review of Asthma Deaths (NRAD) report, ‘Why asthma still kills’, recommended that patients at step 4 or 5 of the British Thoracic Society/Scottish Intercollegiate Guidelines Network (BTS/SIGN) guidance must be referred to a specialist asthma service. This article reviews the 2014 evidence base for therapy of asthma patients at BTS/SIGN step 4 of the treatment cascade, in response to key findings of the NRAD report and lack of preferred treatment option at this step.
PMID: 27651907 [PubMed]
View full post on pubmed: asthma
Conditions: Asthma; Children; Obesity; Maternal
Intervention:
Sponsor: Pontificia Universidad Catolica de Chile
Enrolling by invitation – verified September 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Related Articles |
Effect of high-frequency yoga breathing on pulmonary functions in patients with asthma: A randomized clinical trial.
Ann Allergy Asthma Immunol. 2016 Sep 14;
Authors: Raghavendra P, Shetty P, Shetty S, Manjunath NK, Saoji AA
PMID: 27640077 [PubMed – as supplied by publisher]
View full post on pubmed: asthma
Condition: Inadequately Controlled Asthma
Intervention: Biological: Tralokinumab open-label
Sponsor: AstraZeneca
Not yet recruiting – verified September 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Condition: Asthma
Interventions: Drug: Fluticasone furoate; Drug: Placebo; Drug: Montelukast; Drug: Short Acting Beta 2 Agonist
Sponsor: GlaxoSmithKline
Not yet recruiting – verified August 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Condition: Asthma
Interventions: Drug: Indacaterol acetate 75 ?g; Drug: Indacaterol acetate 150 ?g
Sponsor: Novartis Pharmaceuticals
Not yet recruiting – verified August 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Condition: Patients With Asthma-COPD Overlap Syndrome (ACOS)
Intervention:
Sponsors: AstraZeneca; ASK CRE Private Limited
Not yet recruiting – verified August 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days